Abstract:Background Hepatocellular carcinoma (HCC) is the second-highest cause of malignancy-related death worldwide, and many physiological and pathological processes, including cancer, are regulated by microRNAs (miRNAs). miR-193a-3p is an anti-oncogene that plays an important part in health and disease biology by interacting with specific targets and signals. Methods In vitro assays were performed to explore the influences of miR-193a-3p on the propagation and apoptosis of HCC cells. The sequencing data for HCC were obtained from The Cancer Genome Atlas (TCGA), and the expression levels of miR-193a-3p in HCC and non-HCC tissues were calculated. The differential expression of miR-193a-3p in HCC was presented as standardized mean difference (SMD) with 95% confidence intervals (CIs) in Stata SE. The impact of miR-193a-3p on the prognoses of HCC patients was determined by survival analysis. The potential targets of miR-193a-3p were then predicted using miRWalk 2.0 and subjected to enrichment analyses, including Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Protein-Protein Interaction (PPI) network analysis. The interaction between miR-193a-3p and one predicted target, Cyclin D1 (CCND1), was verified by dual luciferase reporter assays and Pearson correlation analysis. Results MiR-193a-3p inhibited the propagation and facilitated the apoptosis of HCC cells in vitro. The pooled SMD indicated that miR-193a-3p had a low level of expression in HCC (SMD: −0.88, 95% CI [−2.36 −0.59]). Also, HCC patients with a higher level of miR-193a-3p expression tended to have a favorable overall survival (OS: HR = 0.7, 95% CI [0.43–1.13], P = 0.14). For the KEGG pathway analysis, the most related pathway was “proteoglycans in cancer”, while the most enriched GO term was “protein binding”. The dual luciferase reporter assays demonstrated the direct interaction between miR-193a-3p and CCND1, and the Pearson correlation analysis suggested that miR-193a-3p was negatively correlated with CCND1 in HCC tissues (R = − 0.154, P = 0.002). Conclusion miR-193a-3p could suppress proliferation and promote apoptosis by targeting CCND1 in HCC cells. Further, miR-193a-3p can be used as a promising biomarker for the diagnosis and treatment of HCC in the future.

Down-regulation of Dicer in Hepatocellular Carcinoma

Downregulated expression of DIXDC1 in hepatocellular carcinoma and its correlation with prognosis

Let-7c Microrna Expression and Clinical Significance in Hepatocellular Carcinoma.

Mir-18A Downregulates DICER1 and Promotes Proliferation and Metastasis of Nasopharyngeal Carcinoma.

Dicer Expression in Hepatocellular Carcinoma and Its Association with Prognosis in Patients Subject to Radical Resection

Expression and Clinical Significance of Dicer in Hilar Cholangiocarcinoma Tissues and Cells

Dicer Suppresses Hepatocellular Carcinoma Via Interleukin-8 Pathway

Expression of Dicer and Its Related Mirnas in the Progression of Prostate Cancer.

Dysregulation of Microrna Biosynthesis Enzyme Dicer Plays an Important Role in Gastric Cancer Progression

Down-regulation of Long Non-coding RNA LINC01554 in Hepatocellular Cancer and Its Clinical Significance.

CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma

Amplification of Hsa-Mir-191/425 Locus Promotes Breast Cancer Proliferation and Metastasis by Targeting DICER1

Clinical significance of down-regulated HINT2 in hepatocellular carcinoma.

The Downregulation of NCRUPAR is Associated with the Clinical Characteristics of Hepatocellular Carcinoma

Downregulation of Mir-136-5p in Hepatocellular Carcinoma and Its Clinicopathological Significance

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells

Down-Regulation of MiR-193a-3p Dictates Deterioration of HCC: A Clinical Real-Time Qrt-Pcr Study

Down-Regulation And Clinical Role Of Mir-30a-5p In Hepatocellular Carcinoma: A Study Based On Public High-Throughput Datasets

Down-regulation of Small Nuclear RNA (snrna) RNU5E-1 in Hepatocellular Carcinoma Presents with Vital Clinical Significance.

Down-Regulation of LncRNA DGCR5 Correlates with Poor Prognosis in Hepatocellular Carcinoma.